Cargando…

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality worldwide, and its epidemiological, clinical, and socioeconomic impact is progressively increasing. A first estimate of the economic burden of COPD in Italy was conducted in 2008 (the SIRIO [...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dal Negro, Roberto W, Bonadiman, Luca, Turco, Paola, Tognella, Silvia, Iannazzo, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365760/ https://www.ncbi.nlm.nih.gov/pubmed/25834458 http://dx.doi.org/10.2147/CEOR.S77504

Ejemplares similares

Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without Long-Term Oxygen Therapy (LTOT)
por: Dal Negro, Roberto W, et al.
Publicado: (2015)

Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values
por: Dal Negro, Roberto W, et al.
Publicado: (2014)

Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment
por: Dal Negro, Roberto W, et al.
Publicado: (2012)

Cost of persistent asthma in Italy
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Sensitivity of the COPD assessment test (CAT questionnaire) investigated in a population of 681 consecutive patients referring to a lung clinic: the first Italian specific study
por: Negro, Roberto W Dal, et al.
Publicado: (2014)

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Cost of acute cough in Italian children
por: Negro, Roberto W Dal, et al.
Publicado: (2018)

Prevalence of different comorbidities in COPD patients by gender and GOLD stage
por: Dal Negro, R. W., et al.
Publicado: (2015)

Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

The Global Usability Score Short-Form for the simplified assessment of dry powder inhalers (DPIs) usability
por: Povero, Massimiliano, et al.
Publicado: (2020)

Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators for severe and very severe COPD patients
por: Negro, Roberto Dal, et al.
Publicado: (2007)

Instant velocity and consistency of emitted cloud change by the different levels of canister filling with Metered Dose Inhalers (MDIs), but not with Soft Mist Inhalers (SMIs): a bench study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

COPD: The Annual Cost-Of-Illness during the Last Two Decades in Italy, and Its Mortality Predictivity Power
por: Dal Negro, Roberto W.
Publicado: (2019)

Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program
por: Bourbeau, Jean, et al.
Publicado: (2019)

Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

Prevalence and clinical features of most frequent phenotypes in the Italian COPD population: the CLIMA Study
por: Dal Negro, Roberto W., et al.
Publicado: (2021)

The Emotional Response to Pandemic of Middle- and High-School Students of an Italian Northern Province: The ERP Study
por: Povero, Massimiliano, et al.
Publicado: (2022)

Acute cough in Italian children: parents’ beliefs, approach to treatment, and the family impact
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

The Extra Cost Due to Non-Adherence to Inhaled Treatments in Adolescents with Mild-to-Moderate Persistent Asthma
por: Dal Negro, Roberto Walter, et al.
Publicado: (2023)

Influenza and influenza-like syndromes: the subjects’ beliefs, the attitude to prevention and treatment, and the impact in Italian general population
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Prevalence of tracheobronchomalacia and excessive dynamic airway collapse in bronchial asthma of different severity
por: Dal Negro, Roberto W, et al.
Publicado: (2013)

Optimizing economic outcomes in the management of COPD
por: Dal Negro, Roberto
Publicado: (2008)

Effects of Adherence to Once-Daily Treatment on Lung Function, Bronchial Hyperreactivity and Health Outcomes in Adolescents with Mild-to-Moderate Asthmoka: A Twelve-Month Survey
por: Dal Negro, Roberto W., et al.
Publicado: (2022)

The contribution of patients’ lung function to the inspiratory airflow rate achievable through a DPIs’ simulator reproducing different intrinsic resistance rates
por: Dal Negro, Roberto W., et al.
Publicado: (2021)

Comparison of Consistency, Feasibility, and Convenience of a Novel Compact System for Assessing Lung Volumes and Carbon Monoxide Diffusing Capacity versus Whole Body Plethysmography
por: Dal Negro, Roberto W, et al.
Publicado: (2021)

Lung Function Can Predict the Expected Inspiratory Airflow Rate through Dry Powder Inhalers in Asthmatic Adolescents
por: Dal Negro, Roberto Walter, et al.
Publicado: (2022)

Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study
por: Dal Negro, Roberto W., et al.
Publicado: (2022)

Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause
por: Dal Negro, Roberto W., et al.
Publicado: (2022)

Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
por: Gutiérrez Villegas, Celia, et al.
Publicado: (2021)

Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study
por: Roggeri, Alessandro, et al.
Publicado: (2014)

The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients
por: Dal Negro, Roberto W, et al.
Publicado: (2016)

Standard spirometry to assess emphysema in patients with chronic obstructive pulmonary disease: the Emphysema Severity Index (ESI)
por: Dal Negro, Roberto W., et al.
Publicado: (2021)

Cough: impact, beliefs, and expectations from a national survey
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Updated Perspectives on Pulmonary Hypertension in COPD
por: Blanco, Isabel, et al.
Publicado: (2020)

Update on obstructive sleep apnea and its relation to COPD
por: Mieczkowski, Brian, et al.
Publicado: (2014)

Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Pulmonary artery stiffness in chronic obstructive pulmonary disease (copd) - the mesa copd study
por: Liu, Chia-Ying, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_u4vcm1c9dhnsi86g3i7l1r09ql